A study assessing the usefulness of measuring platelet function after cardiac surgery
Not Applicable
Completed
- Conditions
- Coronary Artery Disease / Coronary Artery Bypass Graft / Antiplatelet medicationsCirculatory SystemAtherosclerotic heart disease
- Registration Number
- ISRCTN43298975
- Lead Sponsor
- Wolverhampton Coronary Aftercare Support Group (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
1. Male and female patients aged 18 years and over
2. Patient who can give informed consent
3. Patients undergoing first time coronary artery bypass graft (CABG) using cardiopulmonary bypass
Exclusion Criteria
1. Patients who are unable to consent
2. Patients less than 18 years old
3. Severe liver or renal dysfunction (Altered Liver Function Test, Creatinine >200)
4. Patients who are already part of another study
5. Patient with known bleeding diathesis
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Current primary outcome measures as of 01/04/2014:<br>The primary endpoint was to correlate excessive post-operative bleeding defined as blood loss in excess of 2.5 ml/kg/hr in the immediate 3 hours, with the presence of platelet dysfunction as assessed by Multiplate® and TEG. <br><br>Previous primary outcome measures:<br>The primary endpoint is to correlate excessive postoperative bleeding defined as a blood loss of 2.5 ml/kg/hr in the immediate 3 hours and the total bleeding within the first 8 hours post-surgery, with the presence of platelet dysfunction as measured by the Multiplate®.
- Secondary Outcome Measures
Name Time Method Current secondary outcome measures as of 01/04/2014:<br>1. Transfusion requirements for blood and blood products<br>2. Overall blood loss within 8 hours of surgery<br>3. Postoperative complications<br>4. Intensive care unit (ICU) length of stay<br>5. Hospital length of stay<br><br>Previous secondary outcome measures:<br>1. Transfusion requirements for blood and blood products<br>2. Comparison of Multiplate® and TEG<br>3. Postoperative complications<br>4. ICU length of stay<br>5. Hospital length of stay